Analysis of Sirolimus Blood Concentration and Influencing Factors in Pediatric Patients: Implications for Individualized Drug Therapy
Abstract Background and Objective The purpose of this study is to investigate the status of blood concentration of sirolimus (SRL), explore the factors influencing SRL drug blood concentration, and provide guidance for the appropriate utilization of clinical medications. Methods A single-center retr...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-04-01
|
| Series: | Drugs in R&D |
| Online Access: | https://doi.org/10.1007/s40268-025-00506-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849698209660665856 |
|---|---|
| author | Xiaolin Xu Xueting Mao Bo Liu Yixin Sun Xiaoling Cheng Xiaoling Wang Huawei Mao |
| author_facet | Xiaolin Xu Xueting Mao Bo Liu Yixin Sun Xiaoling Cheng Xiaoling Wang Huawei Mao |
| author_sort | Xiaolin Xu |
| collection | DOAJ |
| description | Abstract Background and Objective The purpose of this study is to investigate the status of blood concentration of sirolimus (SRL), explore the factors influencing SRL drug blood concentration, and provide guidance for the appropriate utilization of clinical medications. Methods A single-center retrospective cohort study encompassed 1535 blood drug concentration observations obtained from 249 children from August 2018 to June 2023. Participants were categorized into four groups (A, B, C, and D) on the basis of their blood concentration levels at various time intervals. The analysis focused on identifying the factors that influenced blood concentration in the short- and long-term posttreatment. The primary endpoint was factors affecting the sirolimus blood concentration. The effect of physiopathological indicators on the corrected blood drug concentration (C/D value) was analyzed to avoid the effect of differences in the dose of SRL used in patients on SRL blood concentrations. The multiple linear regression model was used to examine the impact of factors influencing pharmacokinetics and pharmacodynamics on the C/D. Results Analysis of SRL blood concentration monitoring indicated that a majority (60.43%) of patients demonstrated a trough sirolimus concentration (C 0) below the level of the recommended threshold of 5 ng/mL, while approximately 17.7% of patients exceeded 15 ng/mL. The results indicated a noteworthy association between weight and body surface area (BSA) and the C/D of SRL in groups A, B, and D (P < 0.05). Additionally, aspartate transaminase (AST), alanine aminotransferase (ALT), and albumin (ALB) in group A; ALB in group B; and platelet count (PLT) in group C demonstrated a statistically significant correlation with the C/D of SRL (P < 0.05). Conclusions Clinicians should optimize medication plans by considering the child’s weight, BSA, ALT, AST, PLT, ALB, and relevant factors. These findings may serve as a valuable resource for clinicians. |
| format | Article |
| id | doaj-art-a19e10d0faf7425694eff561f6e3ce4a |
| institution | DOAJ |
| issn | 1174-5886 1179-6901 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Drugs in R&D |
| spelling | doaj-art-a19e10d0faf7425694eff561f6e3ce4a2025-08-20T03:18:59ZengAdis, Springer HealthcareDrugs in R&D1174-58861179-69012025-04-01251798810.1007/s40268-025-00506-9Analysis of Sirolimus Blood Concentration and Influencing Factors in Pediatric Patients: Implications for Individualized Drug TherapyXiaolin Xu0Xueting Mao1Bo Liu2Yixin Sun3Xiaoling Cheng4Xiaoling Wang5Huawei Mao6Department of Immunology, Beijing Children’s Hospital, Capital Medical UniversityDepartment of Pharmacy, Beijing Children’s Hospital, Capital Medical UniversityDepartment of Pharmacy, Beijing Children’s Hospital, Capital Medical UniversityDepartment of Pharmacy, Beijing Children’s Hospital, Capital Medical UniversityDepartment of Pharmacy, Beijing Children’s Hospital, Capital Medical UniversityDepartment of Pharmacy, Beijing Children’s Hospital, Capital Medical UniversityDepartment of Immunology, Beijing Children’s Hospital, Capital Medical UniversityAbstract Background and Objective The purpose of this study is to investigate the status of blood concentration of sirolimus (SRL), explore the factors influencing SRL drug blood concentration, and provide guidance for the appropriate utilization of clinical medications. Methods A single-center retrospective cohort study encompassed 1535 blood drug concentration observations obtained from 249 children from August 2018 to June 2023. Participants were categorized into four groups (A, B, C, and D) on the basis of their blood concentration levels at various time intervals. The analysis focused on identifying the factors that influenced blood concentration in the short- and long-term posttreatment. The primary endpoint was factors affecting the sirolimus blood concentration. The effect of physiopathological indicators on the corrected blood drug concentration (C/D value) was analyzed to avoid the effect of differences in the dose of SRL used in patients on SRL blood concentrations. The multiple linear regression model was used to examine the impact of factors influencing pharmacokinetics and pharmacodynamics on the C/D. Results Analysis of SRL blood concentration monitoring indicated that a majority (60.43%) of patients demonstrated a trough sirolimus concentration (C 0) below the level of the recommended threshold of 5 ng/mL, while approximately 17.7% of patients exceeded 15 ng/mL. The results indicated a noteworthy association between weight and body surface area (BSA) and the C/D of SRL in groups A, B, and D (P < 0.05). Additionally, aspartate transaminase (AST), alanine aminotransferase (ALT), and albumin (ALB) in group A; ALB in group B; and platelet count (PLT) in group C demonstrated a statistically significant correlation with the C/D of SRL (P < 0.05). Conclusions Clinicians should optimize medication plans by considering the child’s weight, BSA, ALT, AST, PLT, ALB, and relevant factors. These findings may serve as a valuable resource for clinicians.https://doi.org/10.1007/s40268-025-00506-9 |
| spellingShingle | Xiaolin Xu Xueting Mao Bo Liu Yixin Sun Xiaoling Cheng Xiaoling Wang Huawei Mao Analysis of Sirolimus Blood Concentration and Influencing Factors in Pediatric Patients: Implications for Individualized Drug Therapy Drugs in R&D |
| title | Analysis of Sirolimus Blood Concentration and Influencing Factors in Pediatric Patients: Implications for Individualized Drug Therapy |
| title_full | Analysis of Sirolimus Blood Concentration and Influencing Factors in Pediatric Patients: Implications for Individualized Drug Therapy |
| title_fullStr | Analysis of Sirolimus Blood Concentration and Influencing Factors in Pediatric Patients: Implications for Individualized Drug Therapy |
| title_full_unstemmed | Analysis of Sirolimus Blood Concentration and Influencing Factors in Pediatric Patients: Implications for Individualized Drug Therapy |
| title_short | Analysis of Sirolimus Blood Concentration and Influencing Factors in Pediatric Patients: Implications for Individualized Drug Therapy |
| title_sort | analysis of sirolimus blood concentration and influencing factors in pediatric patients implications for individualized drug therapy |
| url | https://doi.org/10.1007/s40268-025-00506-9 |
| work_keys_str_mv | AT xiaolinxu analysisofsirolimusbloodconcentrationandinfluencingfactorsinpediatricpatientsimplicationsforindividualizeddrugtherapy AT xuetingmao analysisofsirolimusbloodconcentrationandinfluencingfactorsinpediatricpatientsimplicationsforindividualizeddrugtherapy AT boliu analysisofsirolimusbloodconcentrationandinfluencingfactorsinpediatricpatientsimplicationsforindividualizeddrugtherapy AT yixinsun analysisofsirolimusbloodconcentrationandinfluencingfactorsinpediatricpatientsimplicationsforindividualizeddrugtherapy AT xiaolingcheng analysisofsirolimusbloodconcentrationandinfluencingfactorsinpediatricpatientsimplicationsforindividualizeddrugtherapy AT xiaolingwang analysisofsirolimusbloodconcentrationandinfluencingfactorsinpediatricpatientsimplicationsforindividualizeddrugtherapy AT huaweimao analysisofsirolimusbloodconcentrationandinfluencingfactorsinpediatricpatientsimplicationsforindividualizeddrugtherapy |